| The urgent need to remove excess carbon dioxide from Earth’s environment could include enlisting some of our planet’s smallest inhabitants, according to an international research team led by Michael Hochella of the Department of Energy’s Pacific Northwest National Laboratory. | |
| Hochella and his colleagues examined the scientific evidence for seeding the oceans with iron-rich engineered fertilizer particles near ocean plankton. The goal would be to feed phytoplankton, microscopic plants that are a key part of the ocean ecosystem, to encourage growth and carbon dioxide (CO2) uptake. | |
| The analysis article appears in the journal Nature Nanotechnology(“Potential use of engineered nanoparticles in ocean fertilization for large-scale atmospheric carbon dioxide removal”). |
| “The idea is to augment existing processes,” said Hochella, a Laboratory fellow at Pacific Northwest National Laboratory. “Humans have fertilized the land to grow crops for centuries. We can learn to fertilize the oceans responsibly.” | |
| In nature, nutrients from the land reach oceans through rivers and blowing dust to fertilize plankton. The research team proposes moving this natural process one step further to help remove excess CO2 through the ocean. They studied evidence that suggests adding specific combinations of carefully engineered materials could effectively fertilize the oceans, encouraging phytoplankton to act as a carbon sink. The organisms would take up carbon in large quantities. Then, as they die, they would sink deep into the ocean, taking the excess carbon with them. Scientists say this proposed fertilization would simply speed up a natural process that already safely sequesters carbon in a form that could remove it from the atmosphere for thousands of years. | |
| “At this point, time is of the essence,” said Hochella. “To combat rising temperatures, we must decrease CO2 levels on a global scale. Examining all our options, including using the oceans as a CO2 sink, gives us the best chance of cooling the planet.” | |
Pulling insights from the literature |
|
| In their analysis, the researchers argue that engineered nanoparticles offer several attractive attributes. They could be highly controlled and specifically tuned for different ocean environments. Surface coatings could help the particles attach to plankton. Some particles also have light-absorbing properties, allowing plankton to consume and use more CO2. The general approach could also be tuned to meet the needs of specific ocean environments. For example, one region might benefit most from iron-based particles, while silicon-based particles may be most effective elsewhere, they say. | |
| The researchers’ analysis of 123 published studies showed that numerous non-toxic metal-oxygen materials could safely enhance plankton growth. The stability, Earth abundance, and ease of creation of these materials make them viable options as plankton fertilizers, they argue. | |
| The team also analyzed the cost of creating and distributing different particles. While the process would be substantially more expensive than adding non-engineered materials, it would also be significantly more effective. |
News
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]















